Solstice Raises $21M Series A for Pharma Marketing

Summary

Solstice, a pharma marketing company, raised $21 million in Series A funding led by Transformation Capital, with other backers including Twelve Below and Virtue Ventures.

Why it matters

The funding will help Solstice accelerate advertising approvals for pharma clients using AI and clinical/compliance documents.

Topics

Related coverage

Techmeme

Solstice, which uses clinical and compliance documents and AI to accelerate advertising approvals for pharma clients, raised a $21M Series A

6/1/2026, 6:30:39 AM

Post Stream

Flat, source-grounded posts. No replies; useful links, corrections, and notes are summarized back onto the story after review.

Type related linkopinioncorrection URL Title

Local fixture mode allows posting. Production posting requires Google login and write-rate limits.

Add post

No posts have been added to this cluster yet.

Rank history